Pharmacy Focus2 Mars 2023

S1 Ep191: Public Health Matters - Motivational Interviewing

On this month's episode, Dr. Christina Madison speaks with Bruce Berger, PhD, president of Berger Consulting LLC, on how pharmacists should best use motivational interviewing for patients.

Bruce is President of Berger Consulting, LLC and Emeritus Professor at Auburn University. He has developed comMIt (Comprehensive Motivational Interviewing Training for health care providers) and AU MITI (Auburn University Motivational Interviewing Training Institute) and AU MITI (Auburn University Motivational Training Institute.) He has taught motivational interviewing in health care and methods for improving treatment adherence for over 30 years.

He received his BS in Pharmacy from The Ohio State University. After practicing pharmacy for two years he returned to Ohio State and received his Masters and Ph.D. in social and behavioral pharmacy. He taught at Ohio State before moving to West Virginia University in January, 1980. After two years at WVU, Bruce moved to Auburn University and taught there until his retirement from the university in September of 2009.

He has been a consultant and trainer for the US Air Force, VA, US Army, Pfizer, Inc., Procter & Gamble, Abbvie, Novartis, Astra-Zeneca, Sanofi-Aventis, GSK, and over 50 health plans, including Humana, Harvard Pilgrim, Tufts Health, ConnectiCare, Medical Mutual of Ohio and numerous BlueCross BlueShield plans.

Bruce’s Website: mihcp.com
LinkedIn Profile: https://www.linkedin.com/in/bruce-berger-phd-b557a2b/
Purdue University - Bruce’s MI Elearning website: https://tinyurl.com/PurdueCE-MI-HCP

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(362)

S2 Ep99: October Neurology News: Huntington Disease Gene Therapy, Remibrutinib in MS, and AI Medical Advice

In this update episode of Mind the Meds, host Erica Marini, PharmD, MS, BCPS, opens with regulatory news. The FDA accepted uniQure’s application for AMT-130, a gene therapy for Huntington disease, und...

5 Nov 15min

S2 Ep98: What Cannabis Rescheduling Means for Pharmacists, Patients, and Psychiatric Care

In this episode of Psychiatric Pharmacy Pulse, host Megan Maroney, PharmD, BCPP, FAAPP, talks with Mary Bridgeman, PharmD, a pharmacist and clinical professor at the Ernest Mario School of Pharmacy at...

15 Okt 25min

S2 Ep97: Inside the New Consensus Recommendations for Acute Stroke Care

In this episode of Mind the Meds, host Erica Marini, PharmD, opens with the month's neurology pharmacy news: Novartis and Bristol Myers Squibb paused CAR T-cell trials in autoimmune diseases, includin...

8 Okt 56min

S2 Ep96: How Community Pharmacies Help Patients Quit Smoking

Cindy Valencia, PhD, MPH, is director of CA Quits at UC Davis Health Center for Healthcare Policy and Research. They can be found on LinkedIn. Robin Corelli, PharmD, is a professor of clinical pharmac...

25 Sep 32min

S2 Ep95: Centanafadine May Offer Second-Line Option for Patients With ADHD If Stimulants Fail

In this episode of Psychiatric Pharmacy Pulse, host Megan Maroney, PharmD, BCPP, FAAPP, speaks with Danielle Stutzman, PharmD, BCPP, clinical assistant professor at the University of Colorado Skaggs S...

17 Sep 25min

S2 Ep94: Blood Cancer Awareness Month: Advances, Access, and Hope in Blood Cancer Care

15 Sep 29min

S2 Ep93: Vaccine Timing and Safety in Patients With Neurological Diseases

This episode of Mind the Meds features guest Patti Yager-Stone, PharmD, BCPS, a clinical pharmacist in neurology at the Veterans Affairs Medical Center in Portland, Oregon, who oversees infusion manag...

3 Sep 50min

S2 Ep92: Beyond CRS and ICANS: Managing the Delayed Toxicities of Cilta-cel

Sara Scott, PharmD, BCOP, Emma Uchida, PharmD, MBA, BCOP, and Rebecca Gonzalez, PharmD, BCOP, gather for a roundtable on the rare, delayed toxicities associated with ciltacabtagene autoleucel in relap...

28 Aug 50min